Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Analysis

Adma Biologics (ADMA) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 197.43 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 147.68 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 51.41 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 205.00 Bn
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn 732.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 732.49 Mn
Jun 30, 2026 684.21 Mn
Mar 31, 2026 665.18 Mn
Dec 31, 2025 624.24 Mn
Sep 30, 2025 568.69 Mn
Jun 30, 2025 558.38 Mn
Mar 31, 2025 510.57 Mn
Dec 31, 2024 488.68 Mn
Sep 30, 2024 390.62 Mn
Jun 30, 2024 376.40 Mn
Mar 31, 2024 350.88 Mn
Dec 31, 2023 329.18 Mn
Sep 30, 2023 349.00 Mn
Jun 30, 2023 343.03 Mn
Mar 31, 2023 340.79 Mn
Dec 31, 2022 348.46 Mn
Sep 30, 2022 300.56 Mn
Jun 30, 2022 296.93 Mn
Mar 31, 2022 308.03 Mn
Dec 31, 2021 276.25 Mn
API Access

Adma Biologics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADMA&period=max&api_key=YOUR_API_KEY